[go: up one dir, main page]

JPH11299478A - Analysis of metabolism of medicine and instrument therefor - Google Patents

Analysis of metabolism of medicine and instrument therefor

Info

Publication number
JPH11299478A
JPH11299478A JP10124098A JP12409898A JPH11299478A JP H11299478 A JPH11299478 A JP H11299478A JP 10124098 A JP10124098 A JP 10124098A JP 12409898 A JP12409898 A JP 12409898A JP H11299478 A JPH11299478 A JP H11299478A
Authority
JP
Japan
Prior art keywords
culture
tissue
bag
box
predetermined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10124098A
Other languages
Japanese (ja)
Inventor
Yuka Suzuki
由香 鈴木
Hiroko Momose
裕子 百瀬
Yuuko Hamai
憂子 浜井
Akiyo Shigematsu
昭世 重松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SEITAI KAGAKU KENKYUKAI
Original Assignee
SEITAI KAGAKU KENKYUKAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SEITAI KAGAKU KENKYUKAI filed Critical SEITAI KAGAKU KENKYUKAI
Priority to JP10124098A priority Critical patent/JPH11299478A/en
Publication of JPH11299478A publication Critical patent/JPH11299478A/en
Pending legal-status Critical Current

Links

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for analyzing the metabolism of a medicine in a tissue by culturing plural tissue pieces in a culture liquid containing the prescribed medicine, subsequently collecting samples from the plural tissues, respectively, at plural time points and quantifying the medicine or a metabolite in the tissues, respectively. SOLUTION: This method for analyzing the metabolism of a medicine comprises culturing a tissue piece in a culture liquid containing the prescribed medicine, collecting samples from at least one of the tissue piece and the culture liquid at two or more time points, quantitatively analyzing at least one of the non-changed medicine or the metabolites remaining or produced in the sample with the passage of time by the absorption, metabolism and excretion of the medicine in the tissue, and subsequently tracing and organizing the changes in the quantities of the non-changed medicine or metabolite with the passage of time. Therein, a plurality of the tissue pieces are separately or simultaneously cultured in a plurality of culture vessels 1 fixed to the upper surface of a substrate 2 in a mutually connected state. Fine amounts of samples are simultaneously collected from the plural tissue pieces and/or the culture liquid at two or more time points, and then analyzed to determine the medicine-metabolizing function of the tissue such as liver.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は薬物代謝解析方法お
よびそのための器具に関し、特に微量の生体試料で肝臓
等の組織の薬物代謝に関する機能を直接に評価できる薬
物代謝解析方法およびそのための器具に関する。
The present invention relates to a method for analyzing drug metabolism and a device therefor, and more particularly to a method for analyzing drug metabolism and a device therefor which can directly evaluate the function of a tissue such as a liver with respect to drug metabolism using a small amount of a biological sample.

【0002】[0002]

【従来の技術】新薬開発の途上、ヒトの代替物として実
験動物が多く用いられた。しかし、ヒトと実験動物で
は、薬物動態の大きな差が見られ、動物実験の結果安全
とされた薬物でも、ヒトには重篤な副作用が頻発してい
る。
2. Description of the Related Art During the development of new drugs, experimental animals have been widely used as human substitutes. However, there is a great difference in pharmacokinetics between humans and experimental animals, and serious side effects frequently occur in humans even with drugs that are safe as a result of animal experiments.

【0003】薬物の副作用は肝臓での代謝との間に深い
関係があり、肝臓を通過する際の吸収率、肝臓における
代謝率、肝臓からの排泄率を知ることは、その薬物の副
作用を含めた安全性を評価する上で極めて重要である。
これらの諸因子を把握するには、薬物自体(いわゆる未
変化体)および代謝物の残存量あるいは生成量の、時間
の経過に対する変化を追跡することが必要である。その
ための実験方法として、肝臓の一部(例えば肝小葉)
を、目的物質を含む培養液中で培養して、未変化体およ
び代謝物の量の時間的変化を追跡する方法が有用であ
る。
[0003] The side effects of a drug are closely related to metabolism in the liver, and knowing the absorption rate when passing through the liver, the metabolic rate in the liver, and the excretion rate from the liver include the side effects of the drug. Is extremely important in assessing safety.
In order to grasp these factors, it is necessary to track changes in the residual amount or the production amount of the drug itself (so-called unchanged form) and metabolite over time. As an experimental method for this, a part of the liver (for example, liver lobule)
Is cultured in a culture solution containing a target substance, and a method of tracking a temporal change in the amount of an unchanged substance and a metabolite is useful.

【0004】このような培養試験において、目的物質の
濃度や培養液の組成の異なる培養を行なう際に、実験精
度を確保するためには、複数の培養液中の反応を同時に
進行させ、それらの培養液中から分析のための試料を、
多数時点においてそれぞれ同時に採取し、それらの試料
を分析することが望ましい。
[0004] In such a culture test, when performing cultivation with different concentrations of the target substance and the composition of the culture solution, in order to ensure the accuracy of the experiment, reactions in a plurality of culture solutions are allowed to proceed at the same time. A sample for analysis from the culture solution,
It is desirable to collect the samples at multiple points in time and analyze those samples.

【0005】[0005]

【発明が解決しようとする課題】しかし、複数の培養液
の反応を同時に進行させることは容易でも、それぞれの
液から複数の試料を、多数時点で同時に採取し、かつ反
応を直ちに停止させるには、極めて複雑な、従って高価
な装置を必要とした。
However, although it is easy to simultaneously advance the reactions of a plurality of culture solutions, it is necessary to simultaneously sample a plurality of samples from each solution at a number of times and to immediately stop the reactions. Required extremely complex and therefore expensive equipment.

【0006】さらに、培養反応を所望の雰囲気中、例え
ば酸素や炭酸ガスの一定分圧下で、行なう場合には、反
応の同時進行が可能でも、その雰囲気中を通して試料を
多数かつ同時に採取することが、極めて困難であった。
Further, when the culturing reaction is carried out in a desired atmosphere, for example, under a constant partial pressure of oxygen or carbon dioxide gas, even if the reactions can proceed simultaneously, it is possible to collect a large number of samples through the atmosphere at the same time. Was extremely difficult.

【0007】それ故、本発明の目的は、複数の組織片
を、所定の物質が添加された複数の培養液中でそれぞれ
所定の雰囲気の下に培養し、培養中の組織によるその物
質の代謝を解析する方法を提供することにある。
Therefore, an object of the present invention is to culture a plurality of tissue pieces in a plurality of culture solutions to which a predetermined substance has been added, under a predetermined atmosphere, and to metabolize the substance by the tissue during culture. It is to provide a method for analyzing the.

【0008】本発明の目的は、さらに、複数の組織片
を、所定の物質が添加された複数の培養液中でそれぞれ
所定の雰囲気の下に同時進行的に培養し、2以上の時点
でそれぞれの液から試料を同時に採取し、反応を直ちに
停止させて、それらの試料を分析に供することができ、
複数試料の同時採取と反応停止が安価な装置で行なえる
よう改良された方法を提供することにある。
[0008] Another object of the present invention is to simultaneously culture a plurality of tissue pieces in a plurality of culture solutions to which a predetermined substance has been added under a predetermined atmosphere at the same time. Samples can be taken at the same time from the solution, the reaction can be stopped immediately, and those samples can be used for analysis,
It is an object of the present invention to provide an improved method so that simultaneous sampling of a plurality of samples and stopping of the reaction can be performed with an inexpensive apparatus.

【0009】本発明の他の目的(二)は、複数の組織片
を、所定の物質が添加された複数の培養液中でそれぞれ
所定の雰囲気の下に同時進行的に培養し、2以上の時点
でそれぞれの液から試料を同時に採取し、反応を直ちに
停止させて、それらの試料を分析に供することができ
る、簡便、従って安価な装置を提供することにある。
[0009] Another object (2) of the present invention is to simultaneously culture a plurality of tissue pieces in a plurality of culture solutions to which a predetermined substance is added under a predetermined atmosphere, and to simultaneously culture the two or more pieces. It is an object of the present invention to provide a simple and inexpensive apparatus that can simultaneously collect samples from respective liquids at a point in time, immediately stop the reaction, and provide the samples for analysis.

【0010】[0010]

【課題を解決するための手段】本発明の上記目的は、所
定の薬物が添加された培養液中で組織片を培養し、2以
上の時点において組織片及び培養液の少なくとも一方か
ら試料を同時に採取し、薬物の吸収、代謝、及び排泄の
結果、試料中に経時的に残存又は生成した未変化体及び
代謝物の少なくとも一方を定量分析して、これら未変化
体及び代謝物の量の時間的変化を追跡することにより、
組織による薬物代謝を解析する方法において、複数の組
織片をそれぞれ、互いに連結、固定された複数の培養容
器中において培養液中で個別にしかし同時に培養し、2
以上の時点においてそれぞれ、複数の組織片及び培養液
の少なくとも一方から試料を同時に採取することを特徴
とする薬物代謝解析方法により、達成された。
SUMMARY OF THE INVENTION The object of the present invention is to cultivate a tissue piece in a culture medium to which a predetermined drug has been added, and to simultaneously obtain a sample from at least one of the tissue piece and the culture medium at two or more time points. As a result of the absorption, metabolism, and excretion of the drug, at least one of the unchanged substance and the metabolite remaining or generated in the sample over time is quantitatively analyzed, and the time of the amount of the unchanged substance and the metabolite is determined. By tracking changes,
In a method of analyzing drug metabolism by a tissue, a plurality of tissue pieces are individually but simultaneously cultured in a culture solution in a plurality of connected and fixed culture vessels, respectively.
At each of the above-mentioned time points, it was achieved by a drug metabolism analysis method, wherein a sample is simultaneously collected from at least one of a plurality of tissue pieces and a culture solution.

【0011】本発明の上記目的は、特に、互いに連結さ
れた培養容器が密閉可能な袋体又は箱体に収められ、そ
の一端に所定の気体を導入するための管が接続され、他
端にはこの袋体中の気体組成が所定の組成に保たれる程
度の大きさの排気孔が設けられており、この袋体中の気
体組成を所定の組成に保つよう、気体導入管から所定の
気体を導入しつつ培養を行なうようにした、上記薬物代
謝解析方法により、さらに効果的に達成された。
[0011] The object of the present invention is particularly to provide a container or container in which culture vessels connected to each other are housed in a sealable bag or box, and a pipe for introducing a predetermined gas is connected to one end of the culture vessel and the other end is connected to the other end. Is provided with an exhaust hole whose size is such that the gas composition in the bag is maintained at a predetermined composition, and a predetermined gas is introduced from the gas introduction pipe so as to maintain the gas composition in the bag at a predetermined composition. The above-described drug metabolism analysis method in which culture was performed while introducing gas was achieved more effectively.

【0012】本発明の上記目的(二)は、互いに連結さ
れた培養容器を密閉可能な袋体又は箱体(筒状のものを
含む)に収め、その一端に所定の気体を導入するための
管を接続し、他端にはこの袋体または箱体中の気体組成
が所定の組成に保たれる程度の大きさの排気孔を設け、
この袋体又は箱体中の気体組成を所定の組成に保つよ
う、気体導入管から所定の気体を導入しつつ培養を行な
うようにした培養器具により、達成された。
[0012] The object (2) of the present invention is to store culture vessels connected to each other in a sealable bag or box (including a cylindrical one) and to introduce a predetermined gas into one end thereof. A pipe is connected, and the other end is provided with an exhaust hole large enough to keep the gas composition in the bag or the box at a predetermined composition,
This was achieved by a culture instrument adapted to carry out culturing while introducing a predetermined gas from a gas inlet tube so as to maintain the gas composition in the bag or the box at a predetermined composition.

【0013】[0013]

【発明の実施の形態】薬物は、合成物に限らず、天然
物、生物体内在物質をも包含する。培養容器の数と組織
片の数は一致するとは限らず、一個の培養容器に2以上
の組織片を収容してもよい。組織片、培養液いずれかか
ら試料を採取してもよく、また組織片及び培養液の両方
から試料を採取してもよい。後者の場合、試料は組織片
及び培養液の両方から同時に採取する。
BEST MODE FOR CARRYING OUT THE INVENTION The drug is not limited to a synthetic product, but also includes a natural product and a substance existing in an organism. The number of culture vessels and the number of tissue pieces are not always the same, and two or more tissue pieces may be accommodated in one culture vessel. A sample may be collected from either a tissue piece or a culture solution, or a sample may be collected from both the tissue piece and the culture solution. In the latter case, samples are taken simultaneously from both the tissue piece and the culture.

【0014】培養容器の形状は発明の効果に関係しない
が、底面が平な皿状(シャーレ状)が実用上便利であ
る。培養液のこぼれるのを防ぐため、培養容器は培養液
の体積の3倍以上の容積をもつことが好ましい。
Although the shape of the culture vessel is not related to the effects of the present invention, a dish-shaped dish with a flat bottom (a Petri dish) is practically convenient. In order to prevent the culture solution from spilling out, the culture vessel preferably has a volume that is at least three times the volume of the culture solution.

【0015】培養容器は、同一雰囲気、同一温度の条件
で、反応時間が共通のものを複数、互いに連結、固定す
る。ただし、必要に応じ、連結された2群以上に分けて
もよい(基板に固定する場合には、2枚以上に分けても
よい)。固定とは、着脱自在も含むものとする。連結さ
れた培養容器の配列は、1列でも、2列以上でも、また
円周上でもよく、任意である。1枚又は2枚以上の基板
に培養容器を固定して互いを連結する場合、基板は化学
的に安定なもの、そして反応温度で変形、変質しないも
のが、好ましい。
A plurality of culture vessels having the same reaction time under the same atmosphere and the same temperature are connected and fixed to each other. However, if necessary, it may be divided into two or more connected groups (when fixed to a substrate, it may be divided into two or more sheets). The term “fixed” includes detachable. The arrangement of the connected culture vessels may be one row, two or more rows, or circumferentially, and is arbitrary. When the culture vessels are fixed to one or more substrates and connected to each other, it is preferable that the substrates are chemically stable and do not deform or deteriorate at the reaction temperature.

【0016】培養は、培養容器内の培養液中で行なわれ
るが、必要に応じて、培養液を培養容器とも所望の雰囲
気中に置いて培養を行なう。この場合、雰囲気の気体組
成を一定に保つためには、培養液容器を適宜の形状の袋
又は箱(以下、袋等という)に収容し、袋等の一端から
所定の組成の気体を適宜の流量で導入し、他端に設けた
適宜の大きさの孔から外界に気体を排出する方法をとる
ことができる。袋等の他端に孔を設ける代わりに、多孔
性の袋(例えば紙袋)等を用いてもよい。培養液の液面
付近では、培養中の組織片から代謝および排泄の結果発
生する水、二酸化炭素、アンモニア、酸化窒素等の気体
の濃度が上昇する傾向があるから、気体の流通を促すと
ともに、所定の組成の気体を袋等に流通させる必要があ
る。密閉容器あるいは気体の出入口が1ヶ所しかない袋
等を用いると、培養液上の気体組成を一定に保つことは
困難である。袋等は、不透明あるいは半透明でもよい
が、透明のものが培養液を観察できて、便利である。半
透明または透明である場合、袋等は有色(波長選択性)
あるいは紫外線不透過性であってもよい。培養器具内部
の滅菌のためには、紫外線透過性であることが好まし
い。
Culture is performed in a culture solution in a culture vessel. If necessary, the culture solution is placed in a desired atmosphere with the culture vessel to perform the culture. In this case, in order to keep the gas composition of the atmosphere constant, the culture solution container is accommodated in a bag or box (hereinafter, referred to as a bag or the like) having an appropriate shape, and a gas having a predetermined composition is appropriately applied from one end of the bag or the like. It is possible to adopt a method in which the gas is introduced at a flow rate and the gas is discharged to the outside through a hole of an appropriate size provided at the other end. Instead of providing a hole at the other end of the bag or the like, a porous bag (for example, a paper bag) or the like may be used. In the vicinity of the liquid surface of the culture solution, since the concentration of water such as water, carbon dioxide, ammonia, and nitric oxide generated as a result of metabolism and excretion from the tissue pieces during culture tends to increase, the flow of gas is promoted, It is necessary to distribute a gas having a predetermined composition through a bag or the like. If a closed container or a bag having only one gas inlet / outlet is used, it is difficult to keep the gas composition on the culture solution constant. The bag or the like may be opaque or translucent, but a transparent bag is convenient because the culture solution can be observed. If translucent or transparent, bags etc. are colored (wavelength selectivity)
Alternatively, it may be impermeable to ultraviolet light. In order to sterilize the inside of the culture instrument, it is preferable to be transparent to ultraviolet rays.

【0017】培養液は、組織の要求する栄養素を十分含
むことが必要である。培養液の量は、組織片の体積の少
なくとも10倍の体積を用いる必要があり、15倍以上
とするのが好ましい。
The culture solution must contain sufficient nutrients required by the tissue. The volume of the culture solution must be at least 10 times the volume of the tissue piece, and is preferably 15 times or more.

【0018】組織片の厚さは1mm以上、3mm以下と
することが好ましい。組織片の作製は、3℃以下で行な
うことが望ましく、0℃に近い温度が好ましい。しか
し、培養液が凍結する温度よりは高い温度とする。組織
片の作製は、20分以内で終わるのが好ましい。組織片
の作製後培養開始までの時間は、10分を超えないこと
が好ましい。
The thickness of the tissue piece is preferably 1 mm or more and 3 mm or less. The preparation of the tissue piece is desirably performed at 3 ° C. or lower, and a temperature close to 0 ° C. is preferable. However, the temperature is higher than the temperature at which the culture solution freezes. The preparation of the tissue piece is preferably completed within 20 minutes. It is preferable that the time from the preparation of the tissue piece to the start of culture does not exceed 10 minutes.

【0019】肝臓の組織片は、肝小葉を単位とし、複数
の肝小葉を含まないようにすることが好ましい。
It is preferable that the liver tissue piece is a unit of liver lobule and does not include a plurality of liver lobules.

【0020】各培養条件の組織片及び培養液から得た試
料から抽出された成分の分離は、例えば1枚の薄層クロ
マトグラフ板上で同時にクロマトグラフ展開を行なうな
ど、極力、同時進行的に行なうことが好ましい。
Separation of components extracted from a tissue slice under each culture condition and a sample obtained from a culture solution can be performed simultaneously and simultaneously as simultaneously as possible, for example, by performing chromatographic development on one thin layer chromatographic plate at the same time. It is preferred to do so.

【0021】図1に本発明に用いる培養容器の連結体を
示す。培養液(図示せず)を入れた培養シャーレ1は、
平らな底を有し、平らな基板2に固定されることにより
一体に連結されている。
FIG. 1 shows a connected body of culture vessels used in the present invention. The culture dish 1 containing a culture solution (not shown)
It has a flat bottom and is integrally connected by being fixed to a flat substrate 2.

【0022】図2に、培養液を一定雰囲気下に置くため
の袋体を具える、本発明に用いる培養器具を示す。培養
シャーレ1は平らな基板2に一列に固定され、筒状の袋
3に収められている。袋3は一端にガス導入管4を、他
端上部に小さい孔5および排気管6を有する。培養のた
めの所望の組成のガスを、ガス導入管4から袋3に供給
する。袋3中の気体の一部は孔5から排気管6を通じて
袋の外へ徐々に放出される。
FIG. 2 shows a culture device used in the present invention, which is provided with a bag for placing a culture solution under a constant atmosphere. The culture dish 1 is fixed in a line to a flat substrate 2 and is housed in a cylindrical bag 3. The bag 3 has a gas introduction pipe 4 at one end and a small hole 5 and an exhaust pipe 6 at the upper end of the other end. A gas having a desired composition for culturing is supplied to the bag 3 from the gas introduction pipe 4. Part of the gas in the bag 3 is gradually released from the hole 5 through the exhaust pipe 6 to the outside of the bag.

【0023】図3に、本発明に用いる培養装置を示す。
基板2に固定された培養シャーレ1を収容した袋3を、
基板2が水平になるように支持台8に載せ、所望の温度
の恒温槽7に収め、図示しない動揺手段で全体を動揺さ
せながら、所要の時間、培養反応を行なわせる。
FIG. 3 shows a culture apparatus used in the present invention.
The bag 3 containing the culture dish 1 fixed to the substrate 2 is
The substrate 2 is placed on a support base 8 so as to be horizontal, placed in a thermostat 7 at a desired temperature, and a culture reaction is performed for a required time while shaking the whole by a shaking means (not shown).

【0024】[0024]

【実施例】以下に実施例を示し、本発明をより具体的に
説明する。 [実施例1]5%のキシリトール及び10ー8 mol/Lのメシ
ル酸ナファモスタットを含むWaymouth培養液(生理的緩
衝塩類、必須アミノ酸、ビタミン類を含む)を準備し、
温度を0℃とした(以下、培養液Aという)。
The present invention will be described more specifically with reference to the following examples. [Example 1] Prepare Waymouth medium containing nafamostat mesilate 5% xylitol and 10 @ 8 mol / L (including physiologically buffered saline, essential amino acids, vitamins),
The temperature was set to 0 ° C. (hereinafter referred to as culture solution A).

【0025】ヒトから手術の際に採取された肝臓の一部
(肝小葉)を、下記組成の潅流液で潅流して組織中の血
液を除去した後、0℃付近の温度に保って輸送した。輸
送の所要時間は約50時間であった。
A part of the liver (liver lobule) collected from a human at the time of surgery is perfused with a perfusion solution having the following composition to remove blood in the tissue, and then transported at a temperature of about 0 ° C. . The transit time was about 50 hours.

【0026】到着後直ちに、肝臓組織をスライス液B中
で厚さ2 mm 、重量約100 mgの薄片にスライスし、液中
に浮遊させた。組織片の重量を測定し、100 mg当たり 1
0 pgのDiazepam(3.7kBqの2ー14Cを含む)を、組織片
を浮遊させたスライス液Bに加え、図1に示すように培
養シャーレ1に入れ、それを基板2に着脱自在に固定し
た。
Immediately after arrival, the liver tissue was sliced into slices having a thickness of 2 mm and a weight of about 100 mg in slice solution B, and suspended in the solution. Weigh the tissue pieces and measure 1 per 100 mg
0 pg of Diazepam (including 2-14 C for 3.7 kBq), was added to the slice liquid B was suspended tissue pieces, placed in a culture dish 1, as shown in FIG. 1, it detachably on the substrate 2 Fixed.

【0027】 [0027]

【0028】基板2を、図2に示すようにポリエチレン
製の筒状の袋3で包み、ガス導入管4から酸素ガスを毎
分100 ミリリットルの液量で供給した。図3に示すように、温
度28℃の恒温槽中で培養反応を開始させた。反応時間
中、基板2上の培養シャーレ1を、図示しない動揺装置
で動揺させて、培養液を攪拌した。
As shown in FIG. 2, the substrate 2 was wrapped in a cylindrical bag 3 made of polyethylene, and oxygen gas was supplied from the gas introduction pipe 4 at a liquid volume of 100 ml / min. As shown in FIG. 3, the culture reaction was started in a thermostat at a temperature of 28 ° C. During the reaction time, the culture dish 1 on the substrate 2 was shaken by a shaking device (not shown), and the culture solution was stirred.

【0029】反応開始から15分、1,2,4,24時間
後に、それぞれの反応時間に対応する基板上の培養容器
群を取り出し、培養液に2ミリリットルのメタノールを添加し
て、反応を停止させた。組織片を培養液から取り出し、
0.5 ミリリットルのメタノール中で温度−25℃で16時間抽出
し、抽出を5回繰り返した後、抽出液を併せ、減圧下に
溶媒を除去した後、20マイクロリットルのメタノールで再溶解
し、各濃縮抽出液をシリカゲル薄層クロマトグラフ板
(Merck 社No. 60F254 )(以下、TLC板)の下端か
ら10 mm の位置に点着した。培養液は遠心分離して、そ
の上清をTLC板に点着した。
After 15 minutes, 1, 2, 4 and 24 hours from the start of the reaction, the culture containers on the substrate corresponding to the respective reaction times are taken out, and 2 ml of methanol is added to the culture solution to stop the reaction. I let it. Remove the tissue piece from the culture,
Extraction was performed in 0.5 ml of methanol at a temperature of −25 ° C. for 16 hours, the extraction was repeated 5 times, the extracts were combined, the solvent was removed under reduced pressure, redissolved in 20 μl of methanol, and concentrated. The extract was spotted at a position 10 mm from the lower end of a silica gel thin layer chromatography plate (Merck No. 60F254) (hereinafter, TLC plate). The culture was centrifuged, and the supernatant was spotted on a TLC plate.

【0030】薄層クロマトグラフ板を下記組成の展開溶
媒で展開し、乾燥させ、イメージングプレート(富士写
真フイルム社、東京)に密着させ、画像解析装置BAS
2000(富士写真フイルム社、東京)で解析した。上記密
着の時間は24時間、48時間、72時間の3段階と
し、所要の画像について最適のものの数値を用いた。 [展開溶媒の組成] クロロホルム 95 部 メタノール 5 部 アンモニア水 0.1部
The thin-layer chromatograph plate is developed with a developing solvent having the following composition, dried, brought into close contact with an imaging plate (Fuji Photo Film Co., Tokyo), and an image analyzer BAS is used.
Analyzed at 2000 (Fuji Photo Film, Tokyo). The contact time was set in three stages of 24 hours, 48 hours, and 72 hours, and the optimal value for the required image was used. [Composition of developing solvent] Chloroform 95 parts Methanol 5 parts Ammonia water 0.1 part

【0031】画像解析により得た各TLC板上の画分の
相対的放射能濃度を、培養開始時点の培養液中放射能濃
度を100とした相対値として表示した。結果は表1及
び表2に示す通りであった。
The relative radioactivity concentration of the fraction on each TLC plate obtained by the image analysis was expressed as a relative value with the radioactivity concentration in the culture solution at the start of the culture as 100. The results were as shown in Tables 1 and 2.

【0032】 表1 培養液中の放射能 培養時間(hr) 0.25 1 2 4 24 未変化体 84.82 0.00 0.00 0.00 0.00 代謝物 M1 0.00 0.00 0.00 0.00 0.00 M2 0.00 0.00 0.00 0.00 0.00 M3 0.25 94.7 91.0 91.4 83.8 Table 1 Radioactivity in culture solution Culture time (hr) 0.25 1 2 4 24 Unchanged 84.82 0.00 0.00 0.00 0.00 Metabolite M1 0.00 0.00 0.00 0.00 0.00 M2 0.00 0.00 0.00 0.00 0.00 M3 0.25 94.7 91.0 91.4 83.8

【0033】 表2 組織片中の放射能 培養時間(hr) 0.25 1 2 4 24 未変化体 U 14.75 0.13 0.20 0.08 0.21 代謝物 M1 0.07 0.00 0.02 0.01 0.01 M2 0.07 0.005 0.007 0.01 0.04 M3 0.05 5.17 8.95 7.98 13.90 代謝物合計 0.19 5.17 8.98 8.00 13.95 未変化体+代謝物 T 14.94 5.30 9.18 8.08 14.16 100 U / T 98.7 2.45 2.18 0.99 1.48 Table 2 Radioactivity in tissue pieces Culture time (hr) 0.25 1 2 4 24 Unchanged substance U 14.75 0.13 0.20 0.08 0.21 Metabolite M1 0.07 0.00 0.02 0.01 0.01 M2 0.07 0.005 0.007 0.01 0.04 M3 0.05 5.17 8.95 7.98 13.90 Total metabolites 0.19 5.17 8.98 8.00 13.95 unchanged + metabolite T 14.94 5.30 9.18 8.08 14.16 100 U / T 98.7 2.45 2.18 0.99 1.48

【0034】表1及び表2に見られるように、反応時間
15分で肝臓組織に取り込まれた薬物は、培養液に加えら
れた薬物の約15%(14.94 +0.25%)、組織中の未変化
体は14.75 %である。この時点で肝臓に吸収された薬物
のうち約 99 %は未変化体のままで存在し(100U/Tの欄
参照)、薬物のごく一部が代謝されたに過ぎない。
As can be seen in Tables 1 and 2, the reaction time
The drug incorporated into the liver tissue in 15 minutes is about 15% (14.94 + 0.25%) of the drug added to the culture, and 14.75% unchanged in the tissue. At this point, about 99% of the drug absorbed into the liver remains unchanged (see 100 U / T column), and only a small portion of the drug has been metabolized.

【0035】1時間経過後には、添加薬物の全てが肝臓
組織内に取り込まれた。そのうち未変化体として組織中
に留まる分は少なく、代謝物M3として大部分が培養液
中に排出されるが、代謝物M3の一部は組織中に残る。
2時間以降でも同様である。他の代謝物M1,M2は、
培養液中にはほとんど認められない。1時間以後組織中
の代謝物M3は増加するが、M1,M2は減少する。
After one hour, all of the added drug was taken into the liver tissue. Among them, a small amount remains in the tissue as unchanged, and most of the metabolite M3 is excreted in the culture solution, but a part of the metabolite M3 remains in the tissue.
The same applies after 2 hours. Other metabolites M1 and M2 are
It is hardly found in the culture solution. After 1 hour, the metabolite M3 in the tissue increases, but M1 and M2 decrease.

【0036】[実施例2]実施例1の[2ー14C]Diazep
amの代わりに ringー14C標識 7-ethoxycoumarinを用い
て、同様の実験及び解析を行なった。展開液として、n-
ヘキサン6部と酢酸エチル4部の混合液を用いた。TL
C板上の放射能の画像解析により得た各画分の相対的放
射能濃度を、培養開始時点の培養液中放射能濃度を10
0とする相対値として表示した結果を、表3及び表4に
示す。3種の代謝物をM11、M12、M13とした。
[0036] [Example 2] [2-14 C] of Example 1 Diazep
The same experiment and analysis were performed using ring- 14C- labeled 7-ethoxycoumarin instead of am. N-
A mixed solution of 6 parts of hexane and 4 parts of ethyl acetate was used. TL
The relative radioactivity concentration of each fraction obtained by image analysis of radioactivity on the C plate was calculated as 10
Tables 3 and 4 show the results expressed as relative values of 0. The three metabolites were designated as M11, M12 and M13.

【0037】 表 3 培養液中の放射能 培養時間(hr) 0.25 1 2 4 24 未変化体 85.2 78.84 57.15 26.25 0.77 代謝物 M11 0.58 1.21 3.34 5.60 1.89 M12 0.00 0.00 0.00 0.00 0.00 M13 1.79 4.21 11.27 29.22 80.45 Table 3 Radioactivity in culture solution Culture time (hr) 0.25 1 24 24 unchanged 85.2 78.84 57.15 26.25 0.77 Metabolite M11 0.58 1.21 3.34 5.60 1.89 M12 0.00 0.00 0.00 0.00 0.00 M13 1.79 4.21 11.27 29.22 80.45

【0038】 表 4 組織片中の放射能 培養時間(hr) 0.25 1 2 4 24 未変化体 11.35 16.83 13.63 15.16 0.91 代謝物 M11 0.098 0.034 0.61 0.62 0.24 M12 0.073 0.315 0.82 1.08 0.53 M13 0.915 4.77 13.29 21.70 14.56 代謝物合計 1.086 5.12 14.72 23.40 15.33 未変化体+代謝物 12.44 21.95 28.35 38.56 16.24Table 4 Radioactivity in tissue pieces Culture time (hr) 0.25 1 24 24 unchanged 11.35 16.83 13.63 15.16 0.91 metabolite M11 0.098 0.034 0.61 0.62 0.24 M12 0.073 0.315 0.82 1.08 0.53 M13 0.915 4.77 13.29 21.70 14.56 Metabolism Total 1.086 5.12 14.72 23.40 15.33 unchanged + metabolite 12.44 21.95 28.35 38.56 16.24

【0039】ringー14C標識 7-ethoxycoumarin の組織
取り込み及び代謝について、表3及び表4から、未変化
体が組織に取り込まれるにつれ、培養液中の未変化体が
減少し、組織中の未変化体は一旦増加するが、24時間
後には大きく減少すること、組織中で生ずる代謝物は主
にM13であること、組織中の代謝物は各成分とも4時間
まで増加するが、24時間では減少する一方、組織中の
未変化体とM13の減少に対応して培養液中のM13が24
時間では著しく増すことがわかる。
Table 3 and Table 4 show the uptake and metabolism of ring- 14C- labeled 7-ethoxycoumarin in the tissues. As the unchanged form was incorporated into the tissue, the unchanged form in the culture solution decreased, and the unconverted form in the tissue decreased. Variants increase once but decrease significantly after 24 hours. Metabolites generated in tissues are mainly M13. Metabolites in tissues increase up to 4 hours for each component. On the other hand, M13 in the culture medium was reduced to 24
It can be seen that the time increases significantly.

【0040】[0040]

【発明の効果】複数の組織片をそれぞれ、互いに連結、
固定された複数の培養容器中において培養液中で個別に
しかし同時に培養し、2以上の時点においてそれぞれ、
複数の組織片及び培養液の少なくとも一方から試料を同
時に採取するようにしたことによって、複数の組織片
を、所定の物質が添加された複数の培養液中でそれぞれ
所定の雰囲気の下に培養し、培養中の組織によるその物
質の代謝を解析することが可能となった。
According to the present invention, a plurality of tissue pieces are connected to each other,
Individually but simultaneously in culture in a plurality of fixed culture vessels, at two or more time points,
By simultaneously collecting a sample from at least one of the plurality of tissue pieces and the culture solution, the plurality of tissue pieces are cultured under a predetermined atmosphere in a plurality of culture solutions to which a predetermined substance is added. It has now become possible to analyze the metabolism of that substance by tissues in culture.

【0041】特に、互いに連結された培養容器を密閉可
能な袋体又は箱体に収め、その一端に所定の気体を導入
するための管を接続し、他端にはこの袋体(又は箱体)
中の気体組成が所定の組成に保たれる程度の大きさの排
気孔を設け、この袋体(又は箱体)中の気体組成を所定
の組成に保つよう、気体導入管から所定の気体を導入し
つつ培養を行なうようにした培養器具を用いることによ
り、複数の組織片を、所定の物質が添加された複数の培
養液中でそれぞれ所定の雰囲気の下に培養し、培養中の
組織による物質の代謝を解析することが、簡便かつ安価
にできるようになった。
In particular, the culture vessels connected to each other are housed in a sealable bag or box, and a tube for introducing a predetermined gas is connected to one end thereof, and the bag (or box) is connected to the other end. )
An exhaust hole having a size enough to keep the gas composition in the predetermined composition is provided, and a predetermined gas is supplied from the gas introduction pipe so as to maintain the gas composition in the bag (or the box) at the predetermined composition. By using a culture instrument adapted to perform culture while being introduced, a plurality of tissue pieces are cultured under a predetermined atmosphere in a plurality of culture solutions to which a predetermined substance is added, respectively. Analyzing the metabolism of substances has become simple and inexpensive.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 本発明に用いる培養容器の連結体の断面図。FIG. 1 is a sectional view of a connected body of a culture vessel used in the present invention.

【図2】 本発明に用いる培養器具の断面図。FIG. 2 is a cross-sectional view of the culture device used in the present invention.

【図3】 本発明に用いる培養装置の説明図。FIG. 3 is an explanatory view of a culture device used in the present invention.

【符号の説明】[Explanation of symbols]

1 培養シャーレ 2 基板 3 袋 4 ガス導入管 5 孔 6 排気管 7 恒温槽 8 支持台 DESCRIPTION OF SYMBOLS 1 Culture Petri dish 2 Substrate 3 Bag 4 Gas introduction pipe 5 Hole 6 Exhaust pipe 7 Constant temperature bath 8 Support stand

Claims (13)

【特許請求の範囲】[Claims] 【請求項1】 所定の薬物が添加された培養液中で組織
片を培養し、2以上の時点において前記組織片及び培養
液の少なくとも一方から試料を採取し、組織での前記薬
物の吸収、代謝、及び排泄の結果、前記試料中に経時的
に残存又は生成した未変化体及び代謝物の少なくとも一
方を定量分析して、前記未変化体及び代謝物の量の時間
的変化を追跡することにより、組織による薬物代謝を解
析する方法において、 複数の組織片をそれぞれ、互いに連結し固定された複数
の培養容器中において前記培養液中で個別にしかし同時
に培養し、2以上の時点においてそれぞれ、前記複数の
組織片及び培養液の少なくとも一方から試料を同時に採
取することを特徴とする、薬物代謝解析方法。
1. A method for culturing a tissue piece in a culture solution to which a predetermined drug has been added, collecting a sample from at least one of the tissue piece and the culture solution at two or more time points, absorbing the drug in tissue, As a result of metabolism and excretion, at least one of an unchanged substance and a metabolite remaining or generated in the sample over time is quantitatively analyzed to track a temporal change in the amount of the unchanged substance and the metabolite. Thus, in a method of analyzing drug metabolism by tissue, a plurality of tissue pieces are individually but simultaneously cultured in the culture solution in a plurality of connected and fixed culture vessels, respectively, at two or more time points, A method for analyzing drug metabolism, comprising simultaneously collecting a sample from at least one of the plurality of tissue pieces and the culture solution.
【請求項2】 前記複数の組織片および培養液の両方か
ら試料を同時に採取する、請求項1の薬物代謝解析方
法。
2. The drug metabolism analysis method according to claim 1, wherein samples are simultaneously collected from both the plurality of tissue pieces and the culture solution.
【請求項3】 前記培養容器が平坦な底を有し、平坦な
基板の上に固定される、請求項1又は2の薬物代謝解析
方法。
3. The method according to claim 1, wherein the culture vessel has a flat bottom and is fixed on a flat substrate.
【請求項4】 前記薬物が放射性標識薬物である、請求
項1、2又は3の薬物代謝解析方法。
4. The method according to claim 1, wherein the drug is a radiolabeled drug.
【請求項5】 前記培養容器が密閉可能な袋体または箱
体に収められ、その一端に所定の気体を導入するための
管が接続され、この袋体または箱体はその中の気体組成
が所定の組成に保たれる程度の大きさの排気孔を有し、
前記袋体または箱体の中の気体組成を所定の組成に保つ
よう、前記管から所定の気体を導入しつつ、前記培養を
行なう、請求項1ないし4のいずれかの薬物代謝解析方
法。
5. The culture vessel is housed in a sealable bag or box, and a tube for introducing a predetermined gas is connected to one end of the culture vessel, and the bag or box has a gas composition therein. Has an exhaust hole of a size that can be maintained at a predetermined composition,
The drug metabolism analysis method according to any one of claims 1 to 4, wherein the culture is performed while introducing a predetermined gas from the tube so as to maintain a gas composition in the bag or the box at a predetermined composition.
【請求項6】 前記複数の培養容器を培養時間を同じく
する群に分け、各群の培養容器をそれぞれ互いに連結、
固定して、群別に前記袋体または箱体に収め、所定の培
養時間が経過したとき、他の群から分離して培養を終了
する、請求項5の薬物代謝解析方法。
6. The plurality of culture vessels are divided into groups having the same culture time, and the culture vessels of each group are connected to each other,
6. The drug metabolism analysis method according to claim 5, wherein the cells are fixed and stored in the bag or box for each group, and when a predetermined culture time has elapsed, the culture is terminated by separating from the other groups.
【請求項7】 前記袋体又は箱体にそれぞれ収めた前記
培養容器の複数の群を、同一の恒温槽中で共通の器具に
より揺動して培養する、請求項5の薬物代謝解析方法。
7. The method for analyzing drug metabolism according to claim 5, wherein a plurality of groups of the culture vessels respectively housed in the bag or the box are shaken and cultured by a common instrument in the same thermostat.
【請求項8】 前記各群の培養容器を、同じ基板上に一
列に並べて配置する、請求項6又は7の薬物代謝解析方
法。
8. The drug metabolism analysis method according to claim 6, wherein the culture vessels of each group are arranged in a line on the same substrate.
【請求項9】 前記組織が肝臓である、請求項1ないし
8いずれかの薬物代謝解析方法。
9. The method according to claim 1, wherein the tissue is a liver.
【請求項10】 前記組織片が肝臓スライスから得たも
のである、請求項9の薬物代謝解析方法。
10. The drug metabolism analysis method according to claim 9, wherein the tissue piece is obtained from a liver slice.
【請求項11】 互いに連結された複数の培養容器と、
これを収める密閉可能な袋体又は箱体と、その一端に接
続された所定の気体を導入するための管と、前記袋体又
は箱体の他端に設けた排気孔から成り、 この排気孔は前記袋体又は箱体中の気体組成を所定の組
成に保ち得る程度の大きさであり、前記袋体又は箱体中
の気体組成を所定の組成に保つよう、気体導入管から所
定の気体を導入しつつ培養を行なうための、培養器具。
11. A plurality of culture vessels connected to each other,
It comprises a sealable bag or box housing this, a pipe connected to one end thereof for introducing a predetermined gas, and an exhaust hole provided at the other end of the bag or box. Is a size that can maintain the gas composition in the bag or the box at a predetermined composition, and a predetermined gas is supplied from the gas introduction pipe so as to maintain the gas composition in the bag or the box at the predetermined composition. A culture instrument for culturing while introducing the cultivation.
【請求項12】 前記培養容器を同じ基板上に配置し
た、請求項11の培養器具。
12. The culture instrument according to claim 11, wherein said culture vessels are arranged on the same substrate.
【請求項13】 互いに連結された複数の培養容器と、
これを収める密閉可能な袋体又は箱体と、その一端に接
続された所定の気体を導入するための管と、前記袋体又
は箱体の他端に設けた、前記袋体又は箱体中の気体組成
を所定の組成に保ち得る程度の大きさの排気孔から成る
培養器具と、この培養器具を一定温度に保つための恒温
液槽と、前記培養容器を揺動するための揺動手段を具え
る、培養装置。
13. A plurality of culture vessels connected to each other,
A bag or box that can be sealed, a pipe for introducing a predetermined gas connected to one end thereof, and the bag or box provided at the other end of the bag or box. A culture device having an exhaust hole large enough to maintain the gas composition at a predetermined composition, a thermostatic bath for maintaining the culture device at a constant temperature, and a rocking means for rocking the culture container. A culture device.
JP10124098A 1998-04-17 1998-04-17 Analysis of metabolism of medicine and instrument therefor Pending JPH11299478A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10124098A JPH11299478A (en) 1998-04-17 1998-04-17 Analysis of metabolism of medicine and instrument therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10124098A JPH11299478A (en) 1998-04-17 1998-04-17 Analysis of metabolism of medicine and instrument therefor

Publications (1)

Publication Number Publication Date
JPH11299478A true JPH11299478A (en) 1999-11-02

Family

ID=14876883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10124098A Pending JPH11299478A (en) 1998-04-17 1998-04-17 Analysis of metabolism of medicine and instrument therefor

Country Status (1)

Country Link
JP (1) JPH11299478A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012075410A (en) * 2010-10-04 2012-04-19 Microbio Corp Anaerobic bacterium culture kit
US9005971B2 (en) 2005-04-22 2015-04-14 Life Technologies Corporation Gas spargers and related container systems
US9376655B2 (en) 2011-09-29 2016-06-28 Life Technologies Corporation Filter systems for separating microcarriers from cell culture solutions
US9643133B2 (en) 2011-09-30 2017-05-09 Life Technologies Corporation Container with film sparger
US10123940B2 (en) 2014-06-26 2018-11-13 Advanced Scientific, Inc. Bag assembly and system for use with a fluid
US10589197B2 (en) 2016-12-01 2020-03-17 Life Technologies Corporation Microcarrier filter bag assemblies and methods of use

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005971B2 (en) 2005-04-22 2015-04-14 Life Technologies Corporation Gas spargers and related container systems
US9259692B2 (en) 2005-04-22 2016-02-16 Life Technologies Corporation Gas spargers and related container systems
US9475012B2 (en) 2005-04-22 2016-10-25 Life Technologies Corporation Gas spargers and related container systems
US9682353B2 (en) 2005-04-22 2017-06-20 Life Technologies Corporation Gas spargers and related container systems
US10328404B2 (en) 2005-04-22 2019-06-25 Life Technologies Corporation Gas spargers and related container systems
JP2012075410A (en) * 2010-10-04 2012-04-19 Microbio Corp Anaerobic bacterium culture kit
US10934514B2 (en) 2011-09-29 2021-03-02 Life Technologies Corporation Filter systems for separating microcarriers from cell culture solutions
US9376655B2 (en) 2011-09-29 2016-06-28 Life Technologies Corporation Filter systems for separating microcarriers from cell culture solutions
US12234439B2 (en) 2011-09-29 2025-02-25 Life Technologies Corporation Filter systems for separating microcarriers from cell culture solutions
US11840684B2 (en) 2011-09-29 2023-12-12 Life Technologies Corporation Filter systems for separating microcarriers from cell culture solutions
US10301585B2 (en) 2011-09-29 2019-05-28 Life Technologies Corporation Filter systems for separating microcarriers from cell culture solutions
US10350554B2 (en) 2011-09-30 2019-07-16 Life Technologies Corporation Container with film Sparger
US10843141B2 (en) 2011-09-30 2020-11-24 Life Technologies Corporation Container with film sparger
US12128367B2 (en) 2011-09-30 2024-10-29 Life Technologies Corporation Container with film sparger
US9643133B2 (en) 2011-09-30 2017-05-09 Life Technologies Corporation Container with film sparger
US10463571B2 (en) 2014-06-26 2019-11-05 Advanced Scientifics, Inc. Bag assembly and bag system for use with a fluid
US10123940B2 (en) 2014-06-26 2018-11-13 Advanced Scientific, Inc. Bag assembly and system for use with a fluid
US10589197B2 (en) 2016-12-01 2020-03-17 Life Technologies Corporation Microcarrier filter bag assemblies and methods of use
US11344827B2 (en) 2016-12-01 2022-05-31 Life Technologies Corporation Microcarrier filter bag assemblies and methods of use
US11890557B2 (en) 2016-12-01 2024-02-06 Life Technologies Corporation Microcarrier filter bag assemblies and methods of use

Similar Documents

Publication Publication Date Title
Musteata et al. In vivo sampling with solid phase microextraction
Wilson et al. Principles and techniques of practical biochemistry
Madara et al. A simple approach to measurement of electrical parameters of cultured epithelial monolayers: use in assessing neutrophil-epithelial interactions
US6758099B2 (en) System and method for optimizing tissue barrier transfer of compounds
CN1179035C (en) Simulated biological dissolution and absorption system
Van Dorpe et al. Brainpeps: the blood–brain barrier peptide database
US8277762B2 (en) Apparatus and methods for evaluating the barrier properties of a membrane
Casciari et al. Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model
US20020110905A1 (en) Perfusion system for cultured cells
US20030068614A1 (en) Transdermal assay with magnetic clamp
JPH0574358B2 (en)
JPH0611236B2 (en) Analysis of cytotoxicity in cell culture equipment
AU2001277887A1 (en) System and method for optimizing tissue barrier transfer of compounds
JPH05508991A (en) cell analyzer
Linhares et al. Capillary ultrafiltration: in vivo sampling probes for small molecules
JPH03501521A (en) Analytical measurement equipment
US20150037903A1 (en) Device and method for dried fluid spot analysis
US7172859B2 (en) System and method for optimizing tissue barrier transfer of compounds
JPH11299478A (en) Analysis of metabolism of medicine and instrument therefor
TW202303146A (en) Bio-chips
DK3221696T3 (en) SYSTEM FOR THE CURRENT ASSESSMENT OF PHARMACEUTICAL SOLUTION, ABSORPTION AND PERMEATION AND METHODS OF USE THEREOF
CN107389776A (en) A kind of analysis method and its application for being used to detect drug distribution
JPS6186904A (en) Dialytic apparatus and sampling apparatus, dialytic cell, dialytic chamber and buffer only used in said apparatus
JPH04507199A (en) Methods and apparatus for performing cytotoxicity assays on tumor cells
JP2002537851A (en) In vitro test method for active substances, device and use thereof

Legal Events

Date Code Title Description
A02 Decision of refusal

Effective date: 20040512

Free format text: JAPANESE INTERMEDIATE CODE: A02